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SI Figure Legends 
 
Fig. S1.  Identification of LSD1 as a responsive gene for the it627 mutant. (A) A phylogenetic tree 
constructed by the neighbor joining method for the full-length amino acid sequences of LSD1 proteins. ce, 
C. elegans; d, D. melanogaster; h, human; m, mouse; sp, S. pombe; x, X. laevis; z, zebrafish. (B) The gata1 
expression in the LPM at 14 hpf in wild-type embryos injected or not with 1 pmole each of the indicated 
morpholino oligonucleotides. (C) The effects of tranylcypromine on the gata1 expression. The embryos 
were treated with 300 μM tranylcypromine in wild-type embryos from 6 to 24 hpf. (D) The gata1 
expression at 14 hpf in wild-type or lsd1it627 embryos injected with or without mRNA encoding the 
indicated LSD1 proteins. (E) The expression and stability of wild-type LSD1 and LSD1ΔC609 proteins in 
4- and 14-hpf embryos were examined by immunoblotting using anti-FLAG antibody. 
 
Fig. S2.  Non-hematopoietic defects in lsd1it627 embryos. (A) Ubiquitous expression of lsd1 in zebrafish 
embryos was impaired in lsd1it627 mutants. The lsd1 expression at the indicated developmental stages was 
analyzed in wild-type or lsd1it627 embryos. (B) The survival rates of lsd1it627 mutants calculated using the 
Kaplan-Meier method. (C) The results of a comparison of the phenotypes between lsd1it627 and gata1m651 
mutants at 4 dpf. The arrows and arrowheads indicate the swim bladder and erythrocytes in the heart, 
respectively. The presence of pale erythrocytes due to erythropoietic defects was detected in both lsd1it627 
and gata1m651 mutants, while defects in the swim bladder were only observed in lsd1it627 mutants.  
 
Fig. S3.  Defects in the expression of hematopoietic markers by the lsd1 downregulation. (A) Defects in 
gata1 upregulation in lsd1it627 embryos. The gata1 expression at the indicated developmental stages was 
analyzed in wild-type or lsd1it627 embryos. (B) Effects of tranylcypromine on ectopic pu.1 expression in 
gata1m651 mutants. The embryos were treated with 300 μM tranylcypromine from 6 to 24 hpf . Arrowheads 
indicate ectopic pu.1 expression. 
 
Fig. S4.  Expression of scl and lmo2 in lsd1it627 embryos. The expression of scl, lmo2 and gata1 at 15 hpf 
in wild-type or lsd1it627 embryos. The arrowheads indicate the posterior LPM. 
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Fig. S5.  Expression of hemangioblast markers in lsd1it627 embryos. The expression of the indicated 
hemangioblast markers at 12 hpf (A) and 15 hpf (B) in wild-type, lsd1it627 or gata1m651 embryos. The 
arrowheads indicate the upregulation of etv2 and fli1a in the posterior LPM of lsd1it627 embryos.  
 
Fig. S6.  Expression of fli1a in lsd1it627 embryos. The fli1a expression at the indicated developmental 
stages in wild-type or lsd1it627 embryos. It is noted that no difference was observed between wild-type or 
lsd1it627 embryos before 15 hpf. 
 
Fig. S7.  Effects of the lsd1 mutation on angiogenesis and vascular morphogenesis. Confocal images of 
Tg(kdrl:EGFP)s843 transgenic wild-type or lsd1it627 embryos at 30 hpf (A) and 55 hpf (B). Fluorescent 
images of Tg(kdrl:EGFP)s843 transgenic wild-type or lsd1it627 embryos at 5 dpf (C). 
 
Fig. S8.  Expression of hematopoietic and endothelial cell markers in etv2-knocked-down lsd1it627 
embryos. The expression of fli1a (A), alas2 (B), biklf (C), flk1 (D) and tie1 (E) in wild-type or lsd1it627 
embryos injected or not with 0.5 pmole etv2MO. The downregulation of alas2 and biklf in lsd1it627 embryos 
(white arrowheads) was rescued by the etv2MO injection (black arrowheads). The upregulation of flk1 and 
tie1, but not fli1a, in lsd1it627 embryos was rescued by the etv2MO injection (arrowheads).  
 
Fig. S9.  Model: the LSD1-Etv2 paradigm in hemangioblast. Etv2 maintains the endothelial characteristics 
in hemangioblasts and inhibits the hematopoietic commitment. LSD1 negatively regulates the gene 
expression of Etv2 and promotes the initiation of hematopoietic differentiation. 
 
Movie S1.  The blood circulation in the dorsal aorta and axial vein at 2 dpf in a wild-type embryo. 
 
Movie S2.  The blood circulation in the dorsal aorta and axial vein at 2 dpf in an lsd1it627 embryo. 
 
Movie S3.  The blood circulation in the dorsal aorta and axial vein at 4 dpf in a wild-type embryo. 
 
Movie S4.  The blood circulation in the dorsal aorta and axial vein at 4 dpf in an lsd1it627 embryo. 
 
Movie S5.  The blood circulation in the dorsal aorta and axial vein at 6 dpf in a wild-type embryo. 
 
Movie S6.  The blood circulation in the dorsal aorta and axial vein at 6 dpf in an lsd1it627 embryo. 
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Table S1 Oligonucleotide primers for ChIP analysis 
Target regions Names Sequences 
up1  etv2.up1.f1 5’-TCGCACAGTTTGGCAACTTAC 
etv2.up1.r1 5’-AGTGCTTTGGACAGATAAGACC 
35 bp enhancer etv2.35bp.f1 5’-AATCTGTGGTCGTGACTCCTG 
etv2.35bp.r1 5’-GTCTGTGCTGGACTGAGGAC 
int2  etv2.int2.f2 5’-AACATTTCCGCTGTCCTTGAG 
etv2.int2.r2 5’-GACATCCCATTCCTAAATCTCAG 
exon8 etv2.exon8.f1 5’-ACGTCTACCGCTTTGTCTGTG 
etv2.exon8.r1 5’-GCTTGTGTTTGCTACAGACTG 
 
 
 
